New York, N.Y., Sept. 21, 2006 The Starr Foundation today announced that it has made a $100 million grant to create a wide-ranging cancer consortium to coordinate the efforts of five internationally renowned research institutions in the fight against cancer. Joining this ambitious undertaking is The Broad Institute of MIT and Harvard, Cold Spring Harbor Laboratory, Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College.
The five will collaborate on research aimed at understanding cancer at its most fundamental levels and at developing new approaches to the prevention, diagnosis and treatment of the many forms of the disease that together constitute one of the greatest threats to human health.
The program, to be known as the Starr Cancer Consortium, will provide an innovative framework for research that brings together world-class biomedical investigators with a critical mass of technology. It will build on the complementary strengths of the five institutions, including one-of-a-kind experience in applying the power of genomics to biomedical problems, a proven expertise in the study of cancer genetics in humans and animals, and a strong clinical operation and vast collection of cancer specimens that offer a crucial resource for studying cancer in humans.
"The opening years of the 21st century have brought dramatic advances in understanding cancer and in putting new discoveries to work for the people who need it most," said Maurice R. Greenberg, Chairman of The Starr Foundation. "Our goal in launching the Starr Cancer Consortium is to bring these exceptional institutions together in a manner that assures maximum efficiency and the greatest firepower in targeting cancer. This will enable us to achieve tangible results more quickly and decisively than any one or two members of the consortium could accomplish working alone."